Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nizatidine (Acinon) is a competitive and reversible histamine H2-receptor antagonist with antacid activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 41.00 | |
1 g | In stock | $ 54.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Nizatidine (Acinon) is a competitive and reversible histamine H2-receptor antagonist with antacid activity. |
Targets&IC50 | H2 receptor:0.9 nM, AChE:6.7 μM |
In vitro | In rats, Nizatidine exhibits its maximum inhibitory effect on gastric acid secretion one hour after administration, with an EC50 value of 1.383 μMol/kg. Intravenous administration of Nizatidine (0.3-3 mg/kg) not only enhances gastrointestinal motility but also suppresses gastric acid secretion, achieving 50% of the maximal effect at a dose of 2.94 mg/kg and 90% at 19.6 mg/kg for rats. |
In vivo | Nizatidine is a reversible, non-competitive inhibitor of acetylcholinesterase (IC50=6.7 μM, Ki=7.4 μM) and a selective antagonist of the histamine H2 receptor, effectively inhibiting gastric acid secretion (IC50=0.9 nM). |
Synonyms | Axid, Acinon, Zanizal |
Molecular Weight | 331.46 |
Formula | C12H21N5O2S2 |
CAS No. | 76963-41-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 61 mg/mL (184 mM)
H2O: 26 mg/mL (78.4 mM)
Ethanol: 15 mg/mL (45.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nizatidine 76963-41-2 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor AChE cancer gastroesophageal reflux disease inhibit intestines ulcers Axid hcc stomach Acinon Inhibitor erosive esophagitis Zanizal acid GERD inhibitor